- Home
- RAYA vs ACXP Comparison
RAYA vs ACXP Comparison
Compare RAYA & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- ACXP
- Stock Information
- Founded
- RAYA 2019
- ACXP 2017
- Country
- RAYA China
- ACXP United States
- Employees
- RAYA N/A
- ACXP N/A
- Industry
- RAYA Metal Fabrications
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- RAYA Consumer Discretionary
- ACXP Health Care
- Exchange
- RAYA Nasdaq
- ACXP Nasdaq
- Market Cap
- RAYA 89.2M
- ACXP 8.4M
- IPO Year
- RAYA 2022
- ACXP 2021
- Fundamental
- Price
- RAYA $2.99
- ACXP $0.47
- Analyst Decision
- RAYA
- ACXP Strong Buy
- Analyst Count
- RAYA 0
- ACXP 2
- Target Price
- RAYA N/A
- ACXP $10.00
- AVG Volume (30 Days)
- RAYA 221.3K
- ACXP 18.6M
- Earning Date
- RAYA 01-01-0001
- ACXP 08-08-2025
- Dividend Yield
- RAYA N/A
- ACXP N/A
- EPS Growth
- RAYA N/A
- ACXP N/A
- EPS
- RAYA N/A
- ACXP N/A
- Revenue
- RAYA $30,300,360.00
- ACXP N/A
- Revenue This Year
- RAYA $20.95
- ACXP N/A
- Revenue Next Year
- RAYA N/A
- ACXP N/A
- P/E Ratio
- RAYA N/A
- ACXP N/A
- Revenue Growth
- RAYA 49.10
- ACXP N/A
- 52 Week Low
- RAYA $0.56
- ACXP $0.30
- 52 Week High
- RAYA $3.03
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- RAYA 74.45
- ACXP 50.20
- Support Level
- RAYA $2.15
- ACXP $0.46
- Resistance Level
- RAYA $2.88
- ACXP $0.52
- Average True Range (ATR)
- RAYA 0.35
- ACXP 0.10
- MACD
- RAYA 0.06
- ACXP -0.01
- Stochastic Oscillator
- RAYA 91.67
- ACXP 22.85
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.